Juvenescence Ltd - 19 Dec 2022 Form 4 Insider Report for AgeX Therapeutics, Inc. (SER)

Role
Director, 10%+ Owner
Signature
/s/ Gregory Bailey, CEO of Juvenescence Ltd.
Issuer symbol
SER
Transactions as of
19 Dec 2022
Net transactions value
$0
Form type
4
Filing time
19 Dec 2022, 15:55:35 UTC
Previous filing
27 Oct 2022
Next filing
08 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGE Warrant to Purchase Common Stock Award $0 +847,457 $0.000000 847,457 19 Dec 2022 Common Stock 847,457 $0.5900 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Warrants issued in connection with the draw of loan funds under a Secured Convertible Promissory Note between the issuer and the reporting person.
F2 The warrants are exercisable for shares of the issuer's common stock upon issuance.

Remarks:

Director by deputization